CureAssist Investors
CureAssist is an innovative organization that has developed an AI-powered digital therapeutics platform specifically designed for diabetes management. Their main goal is to revolutionize the way diabetes is treated by providing personalized and effective solutions through their platform. With the use of artificial intelligence, CureAssist offers tailored treatment plans, real-time monitoring, and personalized coaching to help individuals with diabetes achieve better health outcomes. Their achievements include improving patient adherence to treatment plans, reducing hospitalizations, and empowering individuals to take control of their diabetes management.
Headquarters:
Tallinn, Harjumaa, Estonia
Founded Date:
2018
Industry:
Healthcare Company
Last Funding Date:
2020-10-19
Investors Number:
3
Last Funding Type:
Seed